Successful use of extracorporeal life support and hemadsorption in the context of venlafaxine intoxication requiring cardiopulmonary resuscitation: a case report.
Cardiopulmonary resuscitation
CytoSorb®
ECLS
Takotsubo
Venlafaxine intoxication
Journal
Journal of artificial organs : the official journal of the Japanese Society for Artificial Organs
ISSN: 1619-0904
Titre abrégé: J Artif Organs
Pays: Japan
ID NLM: 9815648
Informations de publication
Date de publication:
28 Apr 2023
28 Apr 2023
Historique:
received:
21
11
2022
accepted:
08
04
2023
medline:
28
4
2023
pubmed:
28
4
2023
entrez:
28
4
2023
Statut:
aheadofprint
Résumé
Venlafaxine is a serotonin and noradrenalin reuptake inhibitor prescribed as an antidepressant. Overdose clinically manifests with neurological, cardiovascular and gastrointestinal abnormalities based on, amongst others, serotonin syndrome and can be life-threatening due to cardiovascular collapse. Besides immediate decontamination via gastric lavage and inhibition of enteral absorption through active charcoal, successful hemadsorption with CytoSorb
Identifiants
pubmed: 37115336
doi: 10.1007/s10047-023-01399-8
pii: 10.1007/s10047-023-01399-8
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2023. The Author(s).
Références
Cipriani A, et al. Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis. Lancet. 2018;391(10128):1357–66.
doi: 10.1016/S0140-6736(17)32802-7
pubmed: 29477251
pmcid: 5889788
Batista M, et al. The spectrum of acute heart failure after venlafaxine overdose. Clin Toxicol (Phila). 2013;51(2):92–5.
doi: 10.3109/15563650.2012.763133
pubmed: 23301719
Shelton RC. Serotonin and norepinephrine reuptake inhibitors. Handb Exp Pharmacol. 2019;250:145–80.
doi: 10.1007/164_2018_164
pubmed: 30838456
Höjer J, Hulting J, Salmonson H. Fatal cardiotoxicity induced by venlafaxine overdosage. Clin Toxicol (Phila). 2008;46(4):336–7.
doi: 10.1080/15563650701358755
pubmed: 18363134
Neil CJ, et al. Occurrence of Tako-Tsubo cardiomyopathy in association with ingestion of serotonin/noradrenaline reuptake inhibitors. Heart Lung Circ. 2012;21(4):203–5.
doi: 10.1016/j.hlc.2011.12.004
pubmed: 22285074
Christoph M, et al. Broken heart syndrome: Tako Tsubo cardiomyopathy associated with an overdose of the serotonin-norepinephrine reuptake inhibitor venlafaxine. Eur Neuropsychopharmacol. 2010;20(8):594–7.
doi: 10.1016/j.euroneuro.2010.03.009
pubmed: 20451358
Pancrazio JJ, et al. Inhibition of neuronal Na+ channels by antidepressant drugs. J Pharmacol Exp Ther. 1998;284(1):208–14.
pubmed: 9435180
Khalifa M, Daleau P, Turgeon J. Mechanism of sodium channel block by venlafaxine in guinea pig ventricular myocytes. J Pharmacol Exp Ther. 1999;291(1):280–4.
pubmed: 10490914
Forsberg S, Abazi L, Forsman P. Successful use of extended cardiopulmonary resuscitation followed by extracorporeal oxygenation after venlafaxine-induced takotsubo cardiomyopathy and cardiac arrest: a case report. J Med Case Rep. 2021;15(1):485.
doi: 10.1186/s13256-021-03031-w
pubmed: 34579764
pmcid: 8477521
Schroeder I, et al. Venlafaxine intoxication with development of takotsubo cardiomyopathy: successful use of extracorporeal life support, intravenous lipid emulsion and CytoSorb®. Int J Artif Organs. 2017;40(7):358–60.
doi: 10.5301/ijao.5000595
pubmed: 28574114
Marquetand C, et al. The use of extracorporeal life support in a patient suffering from venlafaxine intoxication. A case report. J Crit Care Med (Targu Mures). 2020;6(2):120–3.
doi: 10.2478/jccm-2020-0014
pubmed: 32426519
Thomas A, et al. Intravenous lipid emulsion therapy and VA-ECMO rescue therapy for massive venlafaxine and clonazepam overdose. J Clin Toxicol. 2017;7:1–2.
doi: 10.4172/2161-0495.1000368
Masson R, et al. A comparison of survival with and without extracorporeal life support treatment for severe poisoning due to drug intoxication. Resuscitation. 2012;83(11):1413–7.
doi: 10.1016/j.resuscitation.2012.03.028
pubmed: 22469751
Reiter K, et al. In vitro removal of therapeutic drugs with a novel adsorbent system. Blood Purif. 2002;20(4):380–8.
doi: 10.1159/000063108
pubmed: 12169849
Kellum JA, Song M, Venkataraman R. Hemoadsorption removes tumor necrosis factor, interleukin-6, and interleukin-10, reduces nuclear factor-kappaB DNA binding, and improves short-term survival in lethal endotoxemia. Crit Care Med. 2004;32(3):801–5.
doi: 10.1097/01.CCM.0000114997.39857.69
pubmed: 15090965
Lang CN, et al. Use of the CytoSorb adsorption device in MDMA intoxication: a first-in-man application and in vitro study. Intensive Care Med Exp. 2020;8(1):21.
doi: 10.1186/s40635-020-00313-3
pubmed: 32542550
pmcid: 7295925
Mitrovic D, et al. Extracorporeal hemoadsorption with the CytoSorb device as a potential therapeutic option in severe intoxications: Review of the rationale and current clinical experiences. J Clin Pharm Ther. 2022;47(9):1444–51.
doi: 10.1111/jcpt.13724
pubmed: 35924306
Langford NJ, et al. Alternative venlafaxine kinetics in overdose. J Clin Pharm Ther. 2002;27(6):465–7.
doi: 10.1046/j.1365-2710.2002.00438.x
pubmed: 12472987
Lee HM, et al. What are the adverse effects associated with the combined use of intravenous lipid emulsion and extracorporeal membrane oxygenation in the poisoned patient? Clin Toxicol (Phila). 2015;53(3):145–50.
doi: 10.3109/15563650.2015.1004582
pubmed: 25634667